Clinical validation
University Wageningen and Umani Medical participate in a clinical investigation.
The scope of the trials is to perform a clinical validation that the Activator actually activates the human primary or innate immune system for people of any sex or age.
Before and after the treatment we measure the (change) in activity of the neutrophils, a type of white blood cells. The image shows the test set-up for our volunteers.
The investigation is funded by ZonMW and will be performed in the course of Spring 2021 in Bernhoven hospital in Uden. The results will be made available on our website.